Panel Discussion

Saturday, March 8, 2025

10:06 AM - 10:20 AM ET

Panel Moderator(s)

Emmanouil S. Brilakis, MD, PhD

Director, Center for Advanced Coronary Interventions
Minneapolis Heart Institute
Minneapolis, Minnesota, United States

No relationships to disclose
Kevin Croce, MD, PhD

Director of CTO and Complex PCI Programs
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.

Panel Discussant(s)

Lorenzo Azzalini, MD, PhD, MSc

Interventional Cardiologist
University of Washington
Seattle, Washington, United States

No relationships to disclose
Gauravpal Singh Gill, MD

Interventional Cardiologist
James River Cardiology, Virginia, United States

No relationships to disclose
Farouc A. Jaffer, MD, PhD

Director Coronary Intervention and CTO PCI Program
Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts, United States

No relationships to disclose
Jaikirshan Khatri, MD

Director of Cardiac Catheterization Laboratory
Weill Cornell Medical Center, United States

No relationships to disclose
Stephane Rinfret, MD, SM

Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States

Disclosure(s): Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)
Catalin Toma, MD

Associate Professor
University of Pittsburgh Medical Center , Pennsylvania, United States

Disclosure(s): inari: Grant/Research Support (Ongoing)
Brett Wanamaker, MD

Clinical Assistant Professor
University of Michigan
Ann Arbor, Michigan, United States

No relationships to disclose
Gerald S. Werner, MD, PhD, FSCAI

Director
Klinikum Darmstadt GmbH
Darmstadt, Hessen, Germany

No relationships to disclose
Masahisa Yamane, MD

Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan

No relationships to disclose
LY

Laura Young

Cleveland Clinic

Disclosure(s): Abbott Vascular, Boston Scientific, Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Emmanouil S. Brilakis, MD, PhD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Elsevier Publishing: royalties (Ongoing); GE Healthcare: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Hippocrates LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IMDS: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Stallion Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TrueVue Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Lorenzo Azzalini, MD, PhD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Gauravpal Singh Gill, MD: No financial relationships to disclose

Farouc A. Jaffer, MD, PhD: Intravascular Imaging, Durvena, Fastwave: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Massachusetts General Hospital: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Royalty - Canon, Terumo, Spectrawave from IP held by MGH (Ongoing); Shockwave, Novartis, Magenta Medical, Medtronic, Cleerly, Genomadix: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens, Canon, Neovasc/Shockwave, Teleflex, Boston Scientific, Amarin, Heartflow, OrbusNeich: Grant/Research Support (Ongoing)

Jaikirshan Khatri, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

Stephane Rinfret, MD, SM: Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Catalin Toma, MD: inari: Grant/Research Support (Ongoing)

Brett Wanamaker, MD: No financial relationships to disclose

Gerald S. Werner, MD, PhD, FSCAI: Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Masahisa Yamane, MD: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)

Laura Young: Abbott Vascular, Boston Scientific, Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)